Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bailing capsule plus levothyroxine for Hashimoto thyroiditis
ChiCTR2300072286Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bailing jiaonang and levothyroxine sodium in Hashimoto's disease and hypothyroidism (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Change in anti-thyroid peroxidase antibody titer from baseline at 6 months. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
bailing jiaonanglevothyroxine sodium
03
Conditions
Hashimoto's diseasehypothyroidism
Beyond the preview
Go deeper on ChiCTR2300072286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072286.